Tamiflu Shortens Flu Duration Even When Given 48–72 Hours After Symptom Onset

FreeStyle Libre Users Can Now Use an App Instead of the Handheld Device

Topical Ketoconazole as an Alternate Therapy to Antibiotics for Adult Female Acne

Seniors Face High Out-of-Pocket Costs for SGLT2 Inhibitors and GLP1 Agonists Despite Medicare Part D Coverage

Considerations for Famotidine Use During COVID-19

FDA Approves New Beta-3 Agonist to Treat Overactive Bladder

Naproxen versus Low-Dose Colchicine for Acute Gout

By Kevin O. Hwang, MD, MPH

Clinical Considerations Involving the Potential Use of Fenofibrate for COVID19

High A1c in Older Adults Linked With Pancreatic Cancer Risk, But Screening Approaches Remain Unclear

Management of Dyspepsia in the Primary Care Setting